Novel therapeutics for myelofibrosis

Myelofibrosis (MF) includes primary MF, post-essential thrombocythemia MF, and post-polycythemia vera MF. MF is a progressive myeloid neoplasm characterized by ineffective clonal hematopoiesis, extramedullary hematopoiesis, a reactive bone marrow environment resulting in reticulin deposition and fib...

Descripción completa

Detalles Bibliográficos
Autor principal: Lee, Sung-Eun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10133844/
https://www.ncbi.nlm.nih.gov/pubmed/36891574
http://dx.doi.org/10.5045/br.2023.2023012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10133844/
https://www.ncbi.nlm.nih.gov/pubmed/36891574
http://dx.doi.org/10.5045/br.2023.2023012

Ejemplares similares